Question 1

What is ICD-10 code A49.3?

Accepted Answer

A49.3 is the ICD-10-CM diagnosis code for mycoplasma infection, unspecified site. A bacterial infection caused by Mycoplasma organisms that has been identified but the specific location in the body where the infection is occurring is not documented. Mycoplasma bacteria typically cause respiratory infections or urinary tract infections. A49.3 sits in the ICD-10-CM chapter for certain infectious and parasitic diseases (a00-b99), within the section covering other bacterial diseases (a30-a49).

A49.3 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.

Use this code only when the site of infection is truly unspecified; if documentation indicates a specific site (such as respiratory tract or urinary tract), use the more specific Mycoplasma code for that location.

Question 2

Is A49.3 an HCC code?

Accepted Answer

No. A49.3 is a billable ICD-10-CM code but does not map to any payment HCC category under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can still be reported on Medicare Advantage encounter data submissions, but it does not contribute to the beneficiary's Risk Adjustment Factor (RAF) score and therefore does not affect the risk-adjusted capitation payment to the plan. V28 reached 100% phase-in for payment year 2026.

Question 3

Is A49.3 billable?

Accepted Answer

Yes. A49.3 is a billable ICD-10-CM code that can be reported on professional and institutional claims as a primary or secondary diagnosis when the provider documentation supports the specific condition described. Billable codes in ICD-10-CM are coded to the highest level of specificity available for the documented diagnosis. A49.3 is current for fiscal year 2026 and remains in the active CMS ICD-10-CM code set published by the National Center for Health Statistics.

Question 4

What is the V28 vs V24 difference for A49.3?

Accepted Answer

A49.3 does not map to a payment HCC under either the CMS-HCC V28 risk adjustment model or the older V24 model. V28 reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition. Because neither model rewards A49.3 with a risk adjustment factor, it contributes zero to a Medicare Advantage beneficiary's RAF score in either version. Coders should check whether provider documentation supports a more specific child code that does map to a payment HCC.

Question 5

What should coders know when reporting A49.3?

Accepted Answer

Use this code only when the site of infection is truly unspecified; if documentation indicates a specific site (such as respiratory tract or urinary tract), use the more specific Mycoplasma code for that location Query the provider if the infection site can be determined from clinical findings, test results, or treatment documentation, as specificity improves clinical clarity and may affect reimbursement

A49.3

Is A49.3 an HCC code?

What This Code Means

Coding Tips

Code Hierarchy

Open A49.3 in the Interactive Encoder